Sarah Meulebrouck et al.
Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas
Diabetologia 2023, vol. 67, issue 2
doi: 10.1007/s00125-023-06035-x
Sarah Meulebrouck et al.
Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas
Diabetologia 2023, vol. 67, issue 2
doi: 10.1007/s00125-023-06035-x